Clarifies on news item
With reference to news in www.moneycontrol.com dated October 27, 2017 quoting "Torrent Pharma in talks to buy Unichem's domestic business", Unichem Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Unichem Laboratories Ltd
The Exchange has sought clarification from Unichem Laboratories Ltd on October 30, 2017, with reference to news in www.moneycontrol.com dated October 27, 2017 quoting "Torrent Pharma in talks to buy Unichem's domestic business"The reply is awaited. Board Meeting To Be Held On November 3, 2017.
Further to our letter dated October 24, 2017, this is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 3, 2017 to interalia consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30, 2017. Unichem recalls 96,876 bottles of Bisoprolol Fumarate tablets
Unichem Laboratories is recalling 96,876 bottles of Bisoprolol Fumarate tablets used for the treatment of hypertension from the US market. Unichem Pharmaceuticals USA Inc is recalling the tablets... Board Meeting Postponed
This is to inform you that the Board Meeting scheduled for October 31, 2017 is being postponed. The revised date will be intimated. Further, in terms of the Company's Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in shares of the Company which was closed... Board Meeting For Quarterly To Be Held On October 31, 2017
This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, October 31, 2017 to interalia consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30, 2017. Shareholding for the Period Ended September 30, 2017
Unichem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For Quarter Ended 30Th September 2017.
Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit hereunder the statement of Investor Complaints for the quarter ended 30th September 2017. Compliance Certificate For The Period Ended September 30, 2017.
Certificate under regulation 40(9) & 40 (10) of the SEBI (LODR) Regulations, 2015 for the half year ended 30.09.2017. Compliance Certificate For The Period Ended September 30, 2017.
Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.